PHC Holdings Corporation (FRA:2GY)
Germany · Delayed Price · Currency is EUR | Market Cap | 777.79M -8.1% |
| Revenue (ttm) | 1.98B -0.1% |
| Net Income | 19.24M -40.0% |
| EPS | 0.15 -40.4% |
| Shares Out | n/a |
| PE Ratio | 40.44 |
| Forward PE | n/a |
| Dividend | 0.25 (4.19%) |
| Ex-Dividend Date | Sep 29, 2025 |
| Volume | n/a |
| Average Volume | n/a |
| Open | 5.95 |
| Previous Close | 5.85 |
| Day's Range | 5.95 - 5.95 |
| 52-Week Range | 4.96 - 6.55 |
| Beta | n/a |
| RSI | 65.10 |
| Earnings Date | May 11, 2026 |
About PHC Holdings
PHC Holdings Corporation, together with its subsidiaries, provides healthcare digital and precision technology solutions in Japan, Europe, North America, and internationally. The company operates in three segments: Diabetes Management; Healthcare Solutions; and Diagnostic and Life Sciences. It offers precision anatomical pathology for cancer, including tissue processors, digital pathology, and histology consumables; cell growth and preservation, such as CFC-free ultra-low temperature freezers, CO2 incubators, and live cell metabolic analyzer an... [Read more]
News
Epredia and Mindpeak Announce EU Distribution Agreement for AI-Powered Image Recognition in Cancer Diagnostics
RUNCORN, United Kingdom--(BUSINESS WIRE)-- #AI--Epredia, a global leader in precision cancer diagnostics and a subsidiary of PHC Holdings Corporation (TSE: 6523), and Mindpeak, a leading provider of a...